Analysis of tumor reoxygenation using ^<31>P-MRS and hypoxic cell imaging
Analysis of tumor reoxygenation using ^<31>P-MRS and hypoxic cell imaging
批准号:
13670918
负责人:
SAKURAI Hideyuki
金额:
$2.24万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2001
资助国家:
日本
项目状态:
已结题
起止时间:
2001 至 2002
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Tumor hypoxic status causes not only radioresistance but also malignant progression such as metastasis,tissue invasion of the tumor. Non-invasive measurement of tumor hypoxia is available for establishing individualization of the cancer treatment.(1) The amount of hypoxic fraction in a rodent tumor was evaluated by polarographic oxygen electrode, ^31P-MRS, and a newly synthesized hypoxic marker, β-D-IAZGP. We also investigated the relationship between the radiosensrtivity of the tumor and the hypoxic fraction predicted by these 3 methods. Radiosensitivity of the tumor was measured by in vivo/in vitro clonogenic assay. Tumor oxygenation status was also measured directly by polarographic oxygen electrodes and indirectly estimated by ^<31>P-MRS. Higher accumulaion of ^<123>I-β-D-IAZGP was observed in the tumors than that in normal tissues at 24hr after administration. As to biodistribution of ^<125>I-β-D-IAGP,the tumor/blood ratio varted widely, but it was correlated with tumor weight. Me … More an p_O_2 values and β-ATP/Pi, PCr/Pi ratios decreased significantly with the increase in tumor volume. As tumor volume increased, tumor cells became more resistant to radiation. The increase in tumor volume was significantly ccirelated with the recbction in mean p_O_2, decrease in ratios ofβATP/Pi or PCr/Pi, increase in uptake of β-D-IAZGP and redioresistance. Because the uptake of β-D-IAZGP can be measured non-invasively by nuclear medicine techniques, it could be clinically useful for monitoring hypoxia in human tumors.(2) To clarify a correlation between tumor hypoxia and malignant progression, we examined an expression of HIF-1 in the tumor of the stage III uterine cervix cancer. Five-year disease free survival rates were 41.2 % in HIF-1 positive group and 75.6% in HIF-1 negative group with statistical significance. Because strong correlation in distant metastasis was found between HIF-1 positive and negative group, the expression of HIF-1 showed malignant progression of the tumor in the uterine cervix. Less
期刊论文(66)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Imai R: "Small cell lung cancer with a brain metastasis controlled for 5 years : a case report"Jpn J Clin Oncol. 31. 116-118 (2001)
Imai R:“小细胞肺癌脑转移得到控制 5 年:病例报告”Jpn J Clin Oncol。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Sakurai H: "A challenge for Non-small cell lung cancer using hyperthemia"Jpn. J Hyperthennic Oncol. 171. 23-31 (2001)
Sakurai H:“利用热疗治疗非小细胞肺癌的挑战”Jpn。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Islam MS, Sakurai H et al.: "Hyperthetmia-induced apoptosis in two rat yolk sac tumor cell lines with different radiothermosensitivity in vitro"Oncol Rep. 8. 501-407 (2001)
Islam MS、Sakurai H 等人:“体外具有不同放射热敏感性的两种大鼠卵黄囊肿瘤细胞系中的Hyperthetmia-induced 细胞凋亡”Oncol Rep. 8. 501-407 (2001)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Imai R, Sakurai H et al.: "Small cell lung cancer with a brain metastasis controlled for 5 years : a case report"Jpn J Chn Oncol. 31. 116-118 (2001)
Imai R、Sakurai H 等:“小细胞肺癌脑转移控制 5 年:病例报告”Jpn J Chn Oncol。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Sakurai H: "Analysis of recurrence of squamous cell carcinoma of the uterine cervix after definitive radiation therapy alone -patterns of recurrence, latent periods and prognosis"Int.J.Radiat.Oncol.Biol.Phys.. 50・5. 1136-1144 (2001)
Sakurai H:“单纯放射治疗后宫颈鳞状细胞癌复发的分析 - 复发模式、潜伏期和预后”Int.J.Radiat.Oncol.Biol.Phys. 50・5。 (2001)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 51 条
Basic Research for the effect of radiation therapy using artificial intelligence
-
批准号:19H03596
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$10.98万
-
财政年份:2019
-
负责人:SAKURAI Hideyuki
-
依托单位:
Basic research for particle therapy using high enrgy proton in next generation
-
批准号:24390286
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$11.48万
-
财政年份:2012
-
负责人:SAKURAI Hideyuki
-
依托单位:
Analysis for disease mechanism by intracellular elements using microparticle beam
-
批准号:24659556
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$2.41万
-
财政年份:2012
-
负责人:SAKURAI Hideyuki
-
依托单位:
A translational research for promotion of multimodality therapy combined with proton beam therapy
-
批准号:21390338
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$9.82万
-
财政年份:2009
-
负责人:SAKURAI Hideyuki
-
依托单位:
Development of specific radiation therapy targeting hypoxic cells
-
批准号:17591247
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.3万
-
财政年份:2005
-
负责人:SAKURAI Hideyuki
-
依托单位:
国内基金
海外基金
登录
查看更多内容
蛋白精氨酸甲基化转移酶PRMT5调控PPARG促进巨噬细胞M2极化及其在肿瘤中作用的机制研究
-
批准号:82371738
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:郑英霞
-
依托单位:
O6-methyl-dGTP抑制胶质母细胞瘤的作用及分子机制研究
-
批准号:82304565
-
项目类别:青年科学基金项目
-
资助金额:30.00万元
-
批准年份:2023
-
负责人:李瑾
-
依托单位:
放疗通过激活GSDMD诱发细胞焦亡促进肿瘤再增殖的机制研究及干预策略探讨
-
批准号:82373299
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:程进
-
依托单位:
基于“Healthy-NAT-Tumor”三维度的食管鳞癌蛋白组学数据挖掘及其临床意义研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:刘伟
-
依托单位:
TGF-β/lnc-APUE/ZEB1通路促进肝癌转移的机制及生物学意义
-
批准号:32100616
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:李颂扬
-
依托单位:
SLC38A6通过调控天冬氨酸介导的嘧啶合成促进肝癌生长的机制研究
-
批准号:32100626
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:秦望舒
-
依托单位:
血管内皮细胞源性的外泌体通过Notch信号通路增强肿瘤细胞可塑性的机制研究
-
批准号:32100627
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:张宇
-
依托单位:
T细胞受体NRP1作为新型免疫检查点在去势抵抗性前列腺癌中的作用机制研究
-
批准号:32100631
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:刘飞
-
依托单位:
RAI16负调控肿瘤相关巨噬细胞c/EBPβ-TGF-β1通路抑制结直肠癌的机制研究
-
批准号:32100629
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:丁翠玲
-
依托单位:
c-Myc诱导的长链非编码RNA CILR1促进肿瘤细胞有氧糖酵解的作用及机制研究
-
批准号:32100622
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:曹利勉
-
依托单位: